News

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune ...
Dr. Carpenter is researching how T cells respond to tuberculosis in the hopes of preventing active TB disease.
Lab grown models of embryos, made from clusters of stem cells, are getting increasingly complex. Ethicists, regulators and ...
New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...
The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.
A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.
Despite significant advancements in biosensing technologies, the early and accurate diagnosis of cancer remains challenging. In a recent study, researchers from Japan have developed a novel ...
Biomedical engineers have achieved a major breakthrough in organoid research, pushing us closer to a new era of ...
Method combines genomics technologies with computational modeling to predict changes in multicellular behavior, such as cell communication.
Funded primarily by the Jayne Koskinas Ted Giovanis Foundation and the National Institutes of Health, and leveraging prior ...
In a study published in Cell Biomaterials, a team led by chemical and nano engineers at the University of California San ...
A team of scientists has developed a remarkable new approach to modeling how cells behave over time—using a digital "forecast ...